New York 10/4/2013 9:18:16 PM
News / Finance

Legendary Small Cap Investor Irwin “Izzy” Zalcberg’s 13D Filing Indicates Beneficial Ownership of over 5% of the Equity Securities of Arrayit Corporation

Listonstreetpulse.com announces that legendary small cap investor Irwin “Izzy” Zalcberg has filed Schedule 13D with the U.S. Securities and Exchange Commission (SEC), indicating beneficial ownership of over 5% of the equity securities of Arrayit Corporation. The filing shows that Mr. Zalcberg used his personal funds to purchase 4,634,890 common shares of ARYC stock and owns 3,490,000 warrants for a total share count and sole voting power of 8,124,890 shares, which represent 27.4% of the company’s approximately 30 million outstanding shares. 

The filing indicates that the full exercise of Mr. Zalcberg’s common restricted shares and warrants would net the company $2.21 million in total proceeds. The complete SEC 13D filing can be accessed at: http://www.sec.gov/Archives/edgar/data/1084507/000143359113000005/zalcberg_13d.txt. 

Mr. Zalcberg joined the Arrayit Corporation newsletter on May 13, 2013 and led a $175,000 private placement round during the second quarter of 2013. Mr. Zalcberg worked on the Chicago Board Options Exchange and has written an exceptional article for Seeking Alpha entitled “Arrayit Making Genetic Testing Feasible.” The article can be read on-line at: http://seekingalpha.com/article/1632082-arrayit-making-genetic-testing-feasible. Since Mr. Zalcberg’s involvement with ARYC, the company’s shares have gained more than 400% on record trading volume. 

To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/

About Arrayit Corporation                            
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.

About Liston Street Pulse                                                 
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.